Clinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year update

Dispenzieri, AngelaAngelaDispenzieriCoelho, TeresaTeresaCoelhoConceição, IsabelIsabelConceiçãoWaddington-Cruz, MárciaMárciaWaddington-CruzWixner, JonasJonasWixnerKristen, Arnt VArnt VKristenRapezzi, ClaudioClaudioRapezziPlanté-Bordeneuve, ViolaineViolainePlanté-BordeneuveGonzalez-Moreno, JuanJuanGonzalez-MorenoMaurer, Mathew SMathew SMaurerGrogan, MarthaMarthaGroganChapman, DougDougChapmanAmass, LeslieLeslieAmassCHI-CHAO CHAO2023-10-242023-10-242022-121750-1172https://scholars.lib.ntu.edu.tw/handle/123456789/636453Transthyretin amyloidosis (ATTR amyloidosis) is a rare, life-threatening disease caused by the accumulation of variant or wild-type (ATTRwt amyloidosis) transthyretin amyloid fibrils in the heart, peripheral nerves, and other tissues and organs.enAmyloidosis; Cardiomyopathy; Polyneuropathy; Registry; TransthyretinClinical and genetic profile of patients enrolled in the Transthyretin Amyloidosis Outcomes Survey (THAOS): 14-year updatejournal article10.1186/s13023-022-02359-w357173812-s2.0-85132453666https://api.elsevier.com/content/abstract/scopus_id/85132453666